Feedback Loop Between Intracranial Atherosclerosis and Cerebral Small Vessel Disease
1 other identifier
observational
300
1 country
1
Brief Summary
The present study aims at verifying the mutual effects between intracranial large artery atherosclerosis and cerebral small vessel disease on disease progression and prognosis by magnetic resonance imaging, and providing biomarkers for the early prevention and treatment of cerebrovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedFirst Posted
Study publicly available on registry
January 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
July 3, 2024
June 1, 2024
5 years
December 19, 2022
June 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Progression in total cerebral small vessel disease burden
Total cerebral small vessel disease burden is assessed according to a sum of scores of white matter hyperintensity, cerebral microbleeds, lacunes and enlarged perivasular spaces on magnetic resonance imaging sequences.
1-3 YEARS
Frequency of stroke recurrence
The percentage of symptomatic participants who suffer from stroke recurrence after enrollment in the territory of the targeted stenotic vessel.
1-3 YEARS
Secondary Outcomes (1)
Frequency of stroke of asymptomatic participants
1-3 YEARS
Study Arms (1)
Intracranial atherosclerosis and small vessel disease
Patients diagnosed with intracranial large artery atherosclerosis and cerebral small vessel disease based on imaging screening.
Interventions
Imaging diagnostics mainly based on Magnetic resonance imaging.
Eligibility Criteria
Participants with at least on intracranial artery ≥ 50% atherosclerotic stenosis.
You may qualify if:
- Age ≥ 18 years
- At least one intracranial artery ≥ 50% atherosclerotic stenosis
- Modified Rankin Scale \< 2
- Mini-mental State Examination \> 24
You may not qualify if:
- Concurrent ipsilateral extracranial artery ≥ 50% stenosis
- Pregnant women
- Contraindications to magnetic resonance examination (patients with pacemakers, nerve stimulators, artificial metal heart valves and other metal foreign bodies)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chinese PLA General Hospital
Beijing, Beijing Municipality, 100853, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jinhao Lyu
Chinese PLA General Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending physician
Study Record Dates
First Submitted
December 19, 2022
First Posted
January 10, 2023
Study Start
January 1, 2023
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
July 3, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share